SoFi stock falls after announcing $1.5B public offering of common stock
American Healthcare REIT, Inc. (NYSE:AHR) announced Wednesday that it has entered into an additional forward sale agreement related to the public offering of its common stock. The company stated that, following the full exercise of the underwriter’s option, 1,215,000 additional shares of common stock were borrowed and sold by an affiliate of RBC Capital Markets, LLC on Wednesday to hedge obligations under this agreement. AHR is currently trading at $50.50, just shy of its 52-week high of $50.80, after delivering an impressive 75.35% return year-to-date.
The forward sale agreement allows American Healthcare REIT to deliver, upon physical settlement by May 20, 2027, up to 1,215,000 shares to the forward purchaser in exchange for cash proceeds per share at the public offering price, less underwriting discounts, commissions, and subject to adjustments as specified in the agreement. The company indicated it may elect cash or net share settlement, subject to certain conditions.
American Healthcare REIT intends to contribute the net proceeds from the settlement of the forward sale agreement to its operating partnership, American Healthcare REIT Holdings, LP, in exchange for limited partnership units. The operating partnership plans to use the funds for general corporate purposes, including possible future investments. With a market capitalization of $8.73 billion, AHR operates with a moderate debt level of $1.7 billion and maintains a healthy current ratio of 1.53, indicating its liquid assets exceed short-term obligations.InvestingPro analysis suggests AHR is currently trading above its Fair Value, with a high P/E ratio of 287.3. Investors seeking deeper insights can access the comprehensive Pro Research Report, available for AHR and 1,400+ other US equities, offering expert analysis on whether this healthcare REIT deserves its premium valuation.
The additional shares were offered and sold under a prospectus supplement and related prospectus filed with the Securities and Exchange Commission, pursuant to an effective shelf registration statement on Form S-3.
This information is based on a press release statement included in a recent SEC filing.
In other recent news, American Healthcare REIT has made several noteworthy announcements. The company reported strong quarterly results, prompting Truist Securities to raise its price target from $46 to $53 while maintaining a Buy rating. Similarly, KeyBanc Capital Markets increased its price target to $55, citing strong fundamentals in the company’s ISHC and SHOP segments, which make up a significant portion of its net operating income. Additionally, American Healthcare REIT has priced an underwritten public offering of 8.1 million shares of common stock, expected to generate approximately $388.8 million in gross proceeds. This offering is scheduled to close on November 24, 2025, pending customary closing conditions. RBC Capital Markets is acting as the underwriter for this transaction, and the offering includes an option for underwriters to purchase up to an additional 1.215 million shares within a 30-day period. The company plans to settle the transaction through a forward sale agreement with RBC Capital Markets within approximately 18 months.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.